Key result
Higher admission HDL-C linked to ~6% lower in-hospital mortality per mg/dL in infective endocarditis.
Why the study?
Simple parameters to serve as early predictors of prognosis in infective endocarditis are lacking.
Does low HDL-C predict in-hospital mortality in patients with infective endocarditis?
Cohort (n=127)
No
Does low HDL-C predict in-hospital mortality in patients with infective endocarditis?
Odds Ratio: 0.937 (95% CI 0.882–0.996)
p-value: p=0.037
Lower baseline HDL-C levels may serve as a simple, low-cost prognostic biomarker to identify infective endocarditis patients at high risk for in-hospital mortality and complications.
(1) Background: Simple parameters to be used as early predictors of prognosis in infective endocarditis (IE) are lacking. The aim of this study was to evaluate the prognostic role of high-density-lipoprotein cholesterol (HDL-C) and also of total-cholesterol (TC), low-density-lipoprotein cholesterol (LDL-C), and triglycerides, in relation to clinical features and mortality, in IE. (2) Methods: Retrospective analysis of observational data from 127 consecutive patients with a definite diagnosis of IE between 2016 and 2019. Clinical, laboratory and echocardiography data, mortality, and co-morbidities were analyzed in relation to HDL-C and lipid profile. (3) Results: Lower HDL-C levels (p = 0.035) were independently associated with in-hospital mortality. HDL-C levels were also significantly lower in IE patients with embolic events (p = 0.036). Based on ROC curve analysis, a cut-off value was identified for HDL-C equal to 24.5 mg/dL for in-hospital mortality. HDL-C values below this cut-off were associated with higher triglyceride counts (p = 0.008), higher prevalence of S. aureus etiology (p = 0.046) and a higher in-hospital mortality rate (p = 0.004). Kaplan–Meier survival analysis showed higher 90-day mortality in patients with HDL-C ≤ 24.5 mg/dL (p = 0.001). (4) Conclusions: Low HDL-C levels could be used as an easy and low-cost marker of severity in IE, particularly to predict complications, in-hospital and 90-day mortality.
No takes yet. Share an insight, caveat, or question.
Zampino et al. (2022) conducted a cohort in Infective endocarditis (n=127). High-density lipoprotein cholesterol (HDL-C) levels vs. Lower vs. higher HDL-C levels was evaluated on In-hospital mortality (per 1 mg/dL increase in HDL-C) (OR 0.937, 95% CI 0.882-0.996, p=0.037). Higher HDL-C levels at admission were independently associated with a reduced risk of in-hospital mortality (OR 0.937 per 1 mg/dL increase) in patients with infective endocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: